GRALGRAIL, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 16207
Ticker: GRAL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-06-12
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GRAL

Detail

Enriched 2026-08-14 20:47

Market cap: $3,079,290,171.96
Shares outstanding (class): 44,666,234
Shares outstanding (weighted): 44,666,234
SIC: 8071 SERVICES-MEDICAL LABORATORIES
Employees: 910
Location: MENLO PARK, CA
Homepage: https://www.grail.com
Description: GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Market cap and share counts drift.

Funds holding this security

112 funds · 116 positions · $289.88M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$59.81M	0.00%	1,157,294 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$53.81M	0.72%	1,041,295 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$44.44M	0.06%	859,883 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$17.09M	0.02%	330,657 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$15.57M	0.12%	301,344 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$13.49M	0.17%	261,045 NS	FIGI
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$8.54M	0.03%	165,188 NS	FIGI
abrdn Healthcare Investors —	—	$7.43M	0.65%	143,825 NS	FIGI
Inception Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC	—	$6.46M	2.72%	124,996 NS	FIGI
EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust	—	$5.97M	1.54%	115,499 NS	FIGI
PIMCO RAE US Small Fund PIMCO Equity Series	—	$4.89M	0.16%	94,544 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$4.39M	0.66%	85,000 NS	FIGI
abrdn Life Sciences Investors —	—	$3.80M	0.68%	73,603 NS	FIGI
1290 VT GAMCO Small Company Value Portfolio EQ Advisors Trust	—	$3.36M	0.09%	65,000 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$3.02M	0.06%	58,399 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGRAL
FIGI_COMPOSITEBBG01N6CGW43
FIGI_SHARE_CLASSBBG01N6CGX05
CIK0001699031
ISINUS3847471014
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Health Care Providers
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: GRAIL operates medical laboratories for cancer detection tests, fitting healthcare providers.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.